These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8101883)

  • 21. Extracellular striatal concentrations of endogenous 3,4-dihydroxyphenylalanine in the absence of a decarboxylase inhibitor: a dynamic index of dopamine synthesis in vivo.
    Carboni E; Tanda G; Di Chiara G
    J Neurochem; 1992 Dec; 59(6):2230-6. PubMed ID: 1431903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
    Biggs CS; Fisher A; Starr MS
    Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression by alpha-methyltyrosine of ethanol-induced locomotor stimulation: partial reversal by L-dopa.
    Engel J; Strömbom U; Svensson TH; Waldeck B
    Psychopharmacologia; 1974 Jul; 37(3):275-9. PubMed ID: 4153095
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR; Abercrombie ED
    J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microdialysis monitoring of 3,4-dihydroxyphenylalanine accumulation after decarboxylase inhibition: a means to estimate in vivo changes in tyrosine hydroxylase activity of the rat locus ceruleus.
    Robert F; Lambás-Señas L; Ortemann C; Pujol JF; Renaud B
    J Neurochem; 1993 Feb; 60(2):721-9. PubMed ID: 8093483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locomotor activity after nicotine infusions into the fourth ventricle of rats.
    Shoaib M; Stolerman IP
    Pharmacol Biochem Behav; 1994 Jul; 48(3):749-54. PubMed ID: 7938131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic transplants suppress L-DOPA-induced Fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Ishida Y; Kuwahara I; Todaka K; Hashiguchi H; Nishimori T; Mitsuyama Y
    Brain Res; 1996 Jul; 727(1-2):205-11. PubMed ID: 8842399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.
    Schmidt CJ; Black CK; Taylor VL; Fadayel GM; Humphreys TM; Nieduzak TR; Sorensen SM
    Eur J Pharmacol; 1992 Sep; 220(2-3):151-9. PubMed ID: 1425989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of microdialysis for monitoring tyrosine hydroxylase activity in the brain of conscious rats.
    Westerink BH; De Vries JB; Duran R
    J Neurochem; 1990 Feb; 54(2):381-7. PubMed ID: 1967629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pentobarbital inhibits L-DOPA-induced dopamine increases in the rat striatum: An in vivo microdialysis study.
    Adachi YU; Yamada S; Satomoto M; Watanabe K; Higuchi H; Kazama T; Doi M; Sato S
    Brain Res Bull; 2006 May; 69(5):593-6. PubMed ID: 16647588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.
    Iderberg H; McCreary AC; Varney MA; Cenci MA; Newman-Tancredi A
    Neuropharmacology; 2015 Jun; 93():52-67. PubMed ID: 25645393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmitter-like L-3,4-dihydroxyphenylalanine tonically functions to mediate vasodepressor control in the caudal ventrolateral medulla of rats.
    Yue JL; Goshima Y; Misu Y
    Neurosci Lett; 1993 Sep; 159(1-2):103-6. PubMed ID: 8264947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mecamylamine but not the alpha7 receptor antagonist alpha-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine.
    Kempsill FE; Pratt JA
    Br J Pharmacol; 2000 Nov; 131(5):997-1003. PubMed ID: 11053222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DOPA cyclohexyl ester, a DOPA antagonist, blocks the depressor responses elicited by microinjections of nicotine into the nucleus tractus solitarii of rats.
    Murota Y; Fujii M; Sugiyama Y; Funabashi T; Yagami T; Takahashi T; Goshima Y
    Neurosci Lett; 2008 Sep; 442(2):114-7. PubMed ID: 18620021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-dopaergic components in the caudal ventrolateral medulla in baroreflex neurotransmission.
    Miyamae T; Goshima Y; Yue JL; Misu Y
    Neuroscience; 1999; 92(1):137-49. PubMed ID: 10392837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Locomotor activity in rats after administration of nicotinic agonists intracerebrally.
    Reavill C; Stolerman IP
    Br J Pharmacol; 1990 Feb; 99(2):273-8. PubMed ID: 2328395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats.
    Biggs CS; Fowler LJ; Whitton PS; Starr MS
    Eur J Pharmacol; 1996 Mar; 299(1-3):83-91. PubMed ID: 8901010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between a novel cholinergic ion channel agonist, SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats.
    Menzaghi F; Whelan KT; Risbrough VB; Rao TS; Lloyd GK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):393-401. PubMed ID: 8996220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats.
    Miller DW; Abercrombie ED
    J Neurochem; 1999 Apr; 72(4):1516-22. PubMed ID: 10098856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.